S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
NASDAQ:JAZZ

Jazz Pharmaceuticals SEC Filings & 10K Form

$140.70
+3.49 (+2.54 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$138.15
$141.21
50-Day Range
$127.21
$150.96
52-Week Range
$126.01
$189.00
Volume671,626 shs
Average Volume704,081 shs
Market Capitalization$8.63 billion
P/E Ratio148.11
Dividend YieldN/A
Beta0.97

Jazz Pharmaceuticals (NASDAQ:JAZZ) SEC Filings

DateFilerForm TypeView
09/03/2021
3:57 PM
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2021
6:12 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
4:07 PM
Jazz Pharmaceuticals (Filer)
Form PRE 14A
08/10/2021
4:42 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:40 PM
Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:38 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:37 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:35 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:34 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:31 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
5:40 PM
Jazz Pharmaceuticals (Issuer)
Schnee Elmar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
5:37 PM
BERNS PAUL L (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
5:35 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2021
5:32 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:08 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:29 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:28 PM
Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:27 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:25 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:23 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:21 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:18 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:16 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:12 PM
Gray Peter (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:10 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2021
5:09 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2021
3:05 PM
Jazz Pharmaceuticals (Filer)
Form DEFA14A
07/06/2021
5:27 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2021
4:17 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
3:40 PM
Jazz Pharmaceuticals (Filer)
Form DEFA14A
06/09/2021
5:57 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
5:55 PM
Jazz Pharmaceuticals (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2021
4:17 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
3:46 PM
Jazz Pharmaceuticals (Issuer)
Tovey Christopher J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
3:24 PM
Jazz Pharmaceuticals (Issuer)
Tovey Christopher J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2021
6:03 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
3:23 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
3:26 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2021
4:08 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
8:05 AM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
04/20/2021
8:01 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2021
4:32 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/06/2021
5:13 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2021
3:33 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2021
5:36 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2021
3:27 PM
Jazz Pharmaceuticals (Issuer)
Larkin Finbar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
3:25 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
6:35 PM
Jazz Pharmaceuticals (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
6:33 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
6:32 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
6:30 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
6:27 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
3:27 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
5:19 PM
Jazz Pharmaceuticals (Issuer)
Jazz Pharmaceuticals (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
5:17 PM
Jazz Pharmaceuticals (Issuer)
Jazz Pharmaceuticals (Issuer)
Sablich Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
5:14 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
5:07 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:57 PM
Jazz Pharmaceuticals (Issuer)
Larkin Finbar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:51 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:48 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:47 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:01 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
4:10 PM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/23/2021
4:22 PM
Jazz Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/23/2021
3:48 PM
Jazz Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2021
3:44 PM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/11/2021
9:05 AM
Jazz Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G/A
02/10/2021
10:10 AM
Jazz Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2021
8:55 PM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/08/2021
9:25 AM
FMR LLC (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G
02/05/2021
5:08 AM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/04/2021
1:21 PM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/03/2021
5:00 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
7:43 AM
GW PHARMACEUTICALS PLC (Subject)
Jazz Pharmaceuticals (Filed by)
Form DFAN14A
02/03/2021
6:52 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2021
3:22 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
3:35 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2021
3:33 PM
Jazz Pharmaceuticals (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
4:09 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:59 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2020
5:57 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/03/2020
3:26 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2020
6:36 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
3:56 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
5:16 PM
Jazz Pharmaceuticals (Issuer)
Larkin Finbar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
3:42 PM
Jazz Pharmaceuticals (Issuer)
Sohn Catherine A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:33 PM
BERNS PAUL L (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:29 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:26 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
6:24 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
5:05 AM
Jazz Pharmaceuticals (Filer)
Form S-8 POS
11/02/2020
4:24 PM
Jazz Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/02/2020
3:48 PM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2020
3:11 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2020
8:17 AM
BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
10/05/2020
6:21 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
5:48 PM
Jazz Pharmaceuticals (Issuer)
Larkin Finbar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:49 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
4:45 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
4:33 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/17/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.